Verax Biomedical
Medical Products Company
Based in MA
AI Overview
With $1.0M in lobbying spend across 22 quarterly filings, Verax Biomedical is a significant lobbying presence. Their lobbying covers 1 issue area. Active from 2018 to 2023.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $240K |
| 2019 | $240K |
| 2020 | $240K |
| 2021 | $150K |
| 2022 | $120K |
| 2023 | $30K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Verax Biomedical disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
Issues related to Blood Safety
Issues related to Blood Safety, H.R. 5961- Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019, S. 2976- Agriculture, Rural Development, Food an
Issues related to Blood Safety, Implementation of Section 765 of Public Law 116-6
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.